阻塞性睡眠呼吸暂停治疗中患者自定的目标
本研究采用混合方法,先通过焦点小组和访谈确定治疗目标类别,再对536例睡眠外科门诊的成人OSA患者进行横断面调查。主要治疗目标为降低健康风险(35%)、改善睡眠质量(28%)、改善日间嗜睡(21%)和减少鼾声(16%)。主要目标与年龄、日间嗜睡(ESS>10)、PAP使用状态和OSA严重程度相关(均P<.0001),OSA严重程度与选择降低健康风险为目标的比例增加相关(P<.05)。
要点
- 成人OSA患者主要治疗目标依次为降低健康风险35%、改善睡眠质量28%、改善日间嗜睡21%、减少鼾声16%。
- 主要治疗目标与年龄、日间嗜睡(ESS>10)、PAP使用状态及OSA严重程度相关(均P<.0001)。
- OSA严重程度越高,选择降低健康风险为主要目标的比例越高(P<.05)。
核心结论
- 成人OSA治疗目标的选择随年龄、症状、PAP使用史和OSA严重程度而变化。
- 了解患者个体化目标是选择手术或非手术治疗时共享决策过程的关键第一步。
- 以目标为中心的讨论最终确保患者与提供者之间 priorities 和成功定义的一致性。
研究设计与样本
- 混合方法设计,基于半结构式访谈后进行横断面调查。
- 设置:学术医学中心和整合管理式医疗联盟。
- 第一阶段为焦点小组和访谈的定性分析以定义治疗目标类别;第二阶段为横断面调查分析,对象为就诊于睡眠外科门诊的OSA患者,共536例。
- 获取PAP使用情况、Epworth嗜睡量表评分和呼吸暂停低通气指数以确定其对目标选择的影响。
主要发现
- 焦点小组和访谈确定的治疗目标主题包括改善睡眠质量、减少日间嗜睡、降低鼾声和降低健康风险。
- 536例患者报告的主要治疗目标为降低健康风险(35%)、改善睡眠质量(28%)、改善日间嗜睡(21%)和减少鼾声(16%)。
- 主要治疗目标与年龄(P<.0001)、日间嗜睡(ESS>10,P<.0001)、PAP使用状态(P<.0001)和OSA严重程度(AHI,P<.0001)相关。
- OSA严重程度与选择降低健康风险为主要目标的比例增加相关(P<.05)。
临床怎么用
- 作者认为,了解患者个体化目标是选择手术或非手术治疗时共享决策过程的关键第一步;以目标为中心的讨论确保患者与提供者之间 priorities 和成功定义的一致性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To characterize the treatment goals and values of adult patients with obstructive sleep apnea (OSA). STUDY DESIGN: Mixed methods design based on semistructured interviews followed by cross-sectional surveys. SETTING: Academic medical center and integrated managed care consortium. METHODS: Phase 1 involved qualitative analysis of focus groups and interviews to define treatment goal categories. Phase 2 included analysis of cross-sectional surveys on most important treatment goals from patients with OSA presenting to sleep surgery clinic. Positive airway pressure (PAP) use, Epworth Sleepiness Scale score, and apnea-hypopnea index were obtained to determine influences on goal choices. RESULTS: During focus groups and interviews, treatment goal themes identified included improving sleep quality, reducing daytime sleepiness, snoring sound reduction, and health risk reduction. In phase 2, 536 patients were surveyed, and they reported the primary treatment goals of health risk reduction (35%), sleep quality improvement (28%), daytime sleepiness improvement (21%), and snoring sound reduction (16%). The primary treatment goal was associated with age (P < .0001), excessive daytime sleepiness (Epworth Sleepiness Scale score >10, P < .0001), PAP use status (P < .0001), and OSA severity (apnea-hypopnea index, P < .0001). Severity of OSA was associated with increasing proportion of patients choosing health risk reduction as the main treatment goal (P < .05). CONCLUSIONS: Adult OSA treatment goal choices vary with age, symptoms, PAP history, and OSA severity. Understanding patient-specific goals is the essential first step in the shared decision-making process when choosing surgical or nonsurgical treatments. Ultimately, goal-focused discussions ensure alignment of priorities and definitions of success between the patient and the provider.
引用
- Cai Y, Tripuraneni P, Gulati A, et al. Patient-Defined Goals for Obstructive Sleep Apnea Treatment. Otolaryngol Head Neck Surg. 2022. PMID: 35133912. doi:10.1177/01945998221075298
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。